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Thermal incoherent neutron scattering is a powerful tool to study the dynamical properties of condensed soft matter systems at nanometric length scales and time scales between subpicoseconds and several nanoseconds. 1 Due to the dominance of incoherent scattering from hydrogen atoms, neutron scattering gives a moleculeaveraged view of the dynamics of hydrogen-rich macromolecules, such as (bio)polymers. For an overview, the reader may consult Refs. 2 and 3. A particularly interesting field of application is here the study of functional enzyme dynamics upon ligand binding. 4, 5 In the following, we will be concerned with analyzing quasielastic neutron scattering (QENS) spectra from hydrated powders of human acetylcholinesterase (hAChE) with and without a noncovalently bound Huperzine A (HupA) ligand. The data have been collected on the IN6 spectrometer at the Institut Laue-Langevin in Grenoble. The experimental details have been published recently, and a corresponding previous data analysis did not reveal systematic dynamical changes upon binding of the HupA ligand. [6] [7] [8] The term "dynamical changes" concerns here the change of motional amplitudes, which are probed by elastic scattering, and the change of the diffusional/relaxational dynamics, which is probed by quasielastic scattering.
Due to the dominant incoherent scattering of the hydrogen atoms, the differential scattering cross section of the hydrogen-rich hAChE powders, i.e., the measured intensities, may be approximated by
where b H,inc is the incoherent scattering length of hydrogen and S(q, ω) is the dynamic structure factor. The latter is the quantity of interest in neutron spectroscopy and its arguments q = k 0 − k and ω are the momentum and energy transfers from the neutrons to the scattering hydrogen atoms in units of ̵ h. The dynamic structure factor is the time Fourier transform of the intermediate scattering function, F(q, t),
which is a quantum time correlation function. In protein powder samples, where rigid-body motions of whole protein molecules are suppressed, the QENS spectrum has an elastic component and F(q, t) has the generic form
where EISF(q) stands for "elastic incoherent structure factor" and (q, t) is a relaxation function fulfilling (q, 0) = 1 and limt→∞ (q, t) = 0. Definingρα(q, t) = exp(iq ⋅rα(t)) to be the Fourier transformed single particle density of hydrogen atom α at positionrα(t), we have
where δρα(q, t) =ρα(q, t) − ⟨ρα(q, 0)⟩. The symbol ⟨⋯⟩ indicates a quantum thermal average and (q, t) is a quantum time correlation function fulfilling
with β = (kBT) −1 . For the following considerations, we introduce the symmetrized relaxation function
where the q-dependence can be omitted due to the fact that (−q, t) = (q, t) in powder samples. By construction, (+) (q, 0) = 1, and we write with (3),
The overwhelming part of QENS studies is and has been interpreted by using the classical limit of Van Hove's theory, 9 using classical diffusion models to describe the dynamics of the hydrogen atoms. In this case, F (+) (t) is replaced by the classical limit of the intermediate scattering function, F cl (t) = lim̵ h→0 F(t). Besides the fact that recoil effects are neglected, the use of such models becomes to some extent meaningless for complex molecular systems, such as proteins, where each atom participates in a large spectrum of motion types with an associated large spectrum of time scales. 10 Based on these insights, we propose a corresponding analysis of QENS data using a simple minimal model for the intermediate scattering function. The relaxation function (+) (t) is here represented by a stretched Mittag-Leffler (ML) function
which behaves for large arguments as
Γ(1 − αk). Mα > 1 assures that all terms with a slow power law decay ∝ t −γ , with 0 < γ < 1, are included. The Mittag-Leffler function has the series representation 11 Eα(z) = ∑ ∞ n=0 z n Γ(1 + αn) and can be considered as a generalization of the exponential function, which is retrieved for α = 1. Our choice for the relaxation function is motivated by earlier work on protein dynamics studied by (8) with (+) (t) according to (9) . We define here q ≡ |q|. The extraction of the intermediate scattering function from the experimental QENS spectrum is described in the supplementary material. Figure 2 shows for a selected q-value the resolution-broadened model (and by definition noise-free) symmetrized dynamic structure factor
where " * " denotes a convolution integral, S
exp (ω) ∝ exp(−β ̵ hω 2) Sexp(ω) is the symmetrized experimental dynamic structure factor 13 which is normalized such that F (+)
exp (0) = 1, and R(ω) is the resolution function. The latter has been obtained from a vanadium run and has approximately Gaussian shape, with a FWHM of ≈70 µeV. With (8), it follows then that (8), with (+) (t) defined by Eq. (9), for free and HupA-inhibited hAChE (blue and red dots, respectively). The fits are supplemented by estimated here almost invisible error bars.
FIG. 3. EISF obtained from the fit of Expression
The model spectra shown in Fig. 2 have been computed by discrete Fourier transform of Fexp(t) = r(t)F(t) for the full accessible time range of IN6, which is here tmax = 206 ps, and r(t) denotes the resolution window in the time domain. Figure 3 displays the fitted EISF for free and HupA-inhibited hAChE. The results show that the EISF in the latter case is slightly smaller than its counterpart for the free variant. This reflects that the average motional amplitudes of the (hydrogen) atoms become slightly larger in presence of the HupA ligand. This is compatible with the results described in Peters et al. 8 and the work by Balog et al., who find by atomic detail normal mode analysis that binding of the cancer drug methotrexate softens the lowfrequency/large amplitude vibrations of its target protein, dihydrofolate reductase 5 and explain in this way earlier neutron scattering results. 15 The "softening" of the low frequency modes leads, in fact, to smaller force constants for the local harmonic potential of the (hydrogen) atoms and thus to larger motional amplitudes. However, this result cannot be generalized since inverse cases are also reported in the literature. Examples can be found in Refs. 8 and 16. While the EISF expresses the amplitudes of the atomic motions, the parameters τ and α describe their relaxation dynamics and thus truly dynamical properties of hAChE. The q-dependence of τ and α is summarized in Fig. 4 . Blue and red points again represent the fitted parameters for free and HupA-inhibited hAChE, respectively, and the corresponding solid lines correspond to linear fits. One observes that both series for the τ-parameter decay with q, where the one for inhibited hAChE displays larger values as the one for the free counterpart. The decrease of τ with q, which is seen for both free and inhibited hAChE, reflects the fact that localized motions are faster than large scale motions, whereas the general increase of τ upon inhibition of hAChE indicates slower relaxation of the inhibited variant. In contrast to the scale parameter τ, the form parameter α of the relaxation function exhibits a much weaker q-dependence, where the values for the inhibited variant of hAChE are slightly smaller than those of the free one. Noting that α = 1 corresponds to exponential relaxation, this means that the corresponding relaxation dynamics is less exponential for the inhibited variant. In order to understand the physical meaning of the α-parameter, we write the stretched Mittag-Leffler function as a continuous superposition of exponential functions,
which expresses the dynamical heterogeneity in a system that is composed of a large number of atoms and where each atom contributes exponentially with a different relaxation constant, λ. Here both t and λ are dimensionless and
is a normalized relaxation rate spectrum fulfilling
The relaxation rate spectrum, p(λ), may be related to an energy barrier spectrum by assuming that the classical Fourier transformed single particle density, δρ(q, t) = exp(iq ⋅ r(t)) − ⟨exp(iq ⋅ r(0))⟩, diffuses in a "rough" harmonic potential. Abbreviating x(t) ≡ δρ(q, t), we write V(x) = V 0 (x) + δV (x), where V 0 (x) = Kx 2 /2 and δV(x) define, respectively, its smooth and rough component (see panel (a) of Fig. 5 ). The smooth component, V 0 (x), tends to bring x ≡ δρ to zero, while the rough component, δV(x), hinders this process by trapping x in one of the local minima which are separated by a fixed energy barrier, ∆E. The diffusion in the smooth potential is described by an Ornstein-Uhlenbeck process, where the displacement autocorrelation function relaxes exponentially, ⟨x(t)x(0) ⟩   FIG. 4 . Parameters α and τ for free and HupA-inhibited hAChE as a function of q (blue and red, respectively). Points correspond to fitted parameters and solid lines to linear fits. The fits are supplemented by estimated error bars. = ⟨x 2 ⟩exp(−η 0 t), and where the relaxation constant and the diffusion constant are related through D 0 = ⟨x 2 ⟩η 0 . We use now Zwanzig's model 17 for the effective diffusion in an arbitrary rough potential,
2 ), where β = 1/(kBT), which translates thus for an harmonic potential into η = η 0 exp(− [β∆E] 2 ) for the relaxation constant. Introducing the dimensionless energy barrier = β∆E and defining λ = η/η 0 , we may write
which leads to
for the distribution of the dimensionless energy barriers, . Panel (b) of Fig. 5 shows the resulting energy barrier distributions for free and inhibited hAChE (blueish and reddish curves) as a function of q, which indicate that binding of the HupA ligand shifts the energy barriers to slightly higher values and leads at the same time to a slight broadening. Ligand binding thus leads to a "roughening" of the effective potential energy surface. For both series of energy barriers, one observes a shift of the distribution to higher values with increasing q, which corresponds to looking at increasingly localized motions. This means that localized motions take place in a rougher potential than those involving the whole protein, and we note that the energy barrier shift upon fixing of the HupA ligand is more pronounced. Figure 6 resumes the analysis of the QENS experiments on free and HupA-inhibited hAChE in one single sketch. The blue and the red curve correspond here, respectively, to the potential energy surface for free and inhibited hAChE, where the irregularity of the energy barriers correspond to the motional heterogeneity of the dynamics. The reduced curvature in the case of inhibited hAChE (red curve) reflects the abovementioned vibrational mode softening and explains the observed reduction of the EISF. The corresponding increased roughness of the energy surface indicates the energy barrier shift to higher values upon ligand binding. The present work shows that a careful data analysis with an appropriate model for the intermediate scattering function, which essentially reflects its asymptotic slow power law relaxation, allows for an observation of subtle but systematic changes of the enzyme dynamics upon ligand binding. The intuitive interpretation of the results has been obtained by employing Zwanzig's physical model of diffusion in a rough quadratic potential, which translates relaxation rate spectra into energy barrier spectra. It is also worth noting that the typical barrier heights we find in our study are of the same order of magnitude as those given in Frauenfelder's paper on protein energy landscapes, 18 although the latter have been obtained from flash photolysis experiments, which probe in much longer time scales than neutron scattering, and from another protein (myogmobin). This indicates the "universality"and self-similarity of protein dynamics.
We finally note that all numerical and many symbolic calculations have been performed with the Wolfram Mathematica package.
